Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

01 January 2008

Sirolimus measurement by LC-MS/MS without solid phase extraction – overcoming the obstacles

N. W. Brown, P. Arampatzis, C. E. Gonde, M. Pires, J. Tracey, M. Tredger

Ann Transplant 2008; 13(1): 36-36 :: ID: 880193

Abstract

Background: Local clinical practice dictated the need for a 3-4 hour turn-around time for sirolimus (SRL) analysis. Of the many reported methods using LC-MS/MS, most proved unsuitable because they involved time consuming sold-phase extraction (SPE) or markedly over-estimated SRL in patient samples (by 1.5 to 2-fold) and spiked quality assurance samples (by 15-20%), showed poor (>15%) interassay precision or low sensitivity when evaluated in-house.
Material/Methods: Using stepwise optimisation of the pre-treatment, chromatography and tandem-mass spectrometry stages of the method we were able to successfully validate a method to FDA standards. Pretreatment with methanolic NH[sub]4[/sub] CO[sub]3[/sub]/ZnSO[sub]4[/sub] improved precipitation and optimised sirolimus extraction. Chromatography was enhanced using a C8 column and a column purge with 100% methanol reduced apparent ion-enhancement. Mass spectrometry with a low desolvation temperature removed a co-eluting peak.
Results: We identified a lower limit of quantification of 1.5 μg/L, inter-assay precision <12% from 2.9 to 40.0 μg/L and linearity to at least 50 μg/L. Recovery of spiked samples gave a median recovery of 107% and analysis of 27 stored quality assurance samples (patient pools and spiked samples) a median z value of +0.3 compared to the LC-MS/MS group mean. Comparison of results in 186 samples from liver, renal, pancreatic islet and bone marrow transplant recipients showed good agreement with a reference laboratory using LC-MS/MS and SPE: median (interquartile range) bias of +4.30% (-0.10 to 9.03%).
Conclusions: Timely analysis of SRL in patient samples is possible with satisfactory sensitivity and precision using LC-MS/MS without prior SPE.

Keywords: Sirolimus, Chromatography, analysis

Add Comment 0 Comments

In Press

07 Mar 2024 : Original article  

Outcomes of Renal Transplantation in ANCA-Associated Vasculitis

Ann Transplant In Press; DOI: 10.12659/AOT.943433  

08 Mar 2024 : Original article  

Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...

Ann Transplant In Press; DOI: 10.12659/AOT.943532  

14 Mar 2024 : Original article  

Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort Study

Ann Transplant In Press; DOI: 10.12659/AOT.943652  

14 Mar 2024 : Case report  

Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...

Ann Transplant In Press; DOI: 10.12659/AOT.942358  

Most Viewed Current Articles

05 Apr 2022 : Original article  

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

12 Jan 2022 : Original article  

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

22 Nov 2022 : Original article  

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358